研究进展N6Methyladenosine修饰在血管新生,血管新生模仿,以及乳腺癌的治疗影响
Jiachen Weng1, Yisi Shan1, Qingyu Chang1
1Translational Medical Innovation Center, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou City, Jiangsu, 215600, China.
Progress in biophysics and molecular biology
|December 22, 2024
概括
在乳腺癌中,N6-甲基氨酸 (m6A) 修饰至关重要,影响瘤生长和扩散. 这篇评论探讨了m6AA.
科学领域:
- 史诗转录组学 史诗转录组学
- 分子瘤学分子瘤学
- 癌症生物学 癌症生物学
背景情况:
- N6-甲基氨酸 (m6A) 是真核RNA中最常见的表体转录组修饰.
- m6A显著影响RNA代谢,影响瘤发生和癌症进展.
- 乳腺癌研究越来越多地关注m6A的作用.
研究的目的:
- 审查了解乳腺癌中m6A修饰的最新进展.
- 阐明m6A在血管生成和血管生成模拟中的作用.
- 突出m6A调节器及其治疗潜力.
主要方法:
- 关于乳腺癌m6A研究近期进展的文献综述.
- 分析m6A对RNA稳定性,拼接,翻译和降解的影响.
- 在瘤血管生成中检查m6A的"写字器"",擦字器"和"读字器".
主要成果:
- m6A修饰在调节乳腺癌血管生成中的关键因素和信号通路方面发挥着重要作用.
- 这种m6A"写字器"",删字器"和"读字器"的相互作用会影响瘤血管生成和血管生成模拟.
- 通过调节RNA命运,m6A相关的转录会影响瘤的进展.
结论:
- m6A修饰是乳腺癌中血管生成和血管生成模仿的关键调节者.
- 了解m6A的"写","擦"和"读"提供了对乳腺癌机制的见解.
- 准m6A通路为乳腺癌提供了潜在的治疗策略.
相关概念视频
Mechanism of Angiogenesis
5.3K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.3K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


